Patient P-02249
Synthetic patientMETA-24 · Day 173 · 55–64 · F · baseline S09Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
2%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S09
- Day 29 DT-01 recommended — Dosing / Timing Recommendation DT-01
- Day 30 Patient accepted — Started DT-01 in the companion
- Day 35 GI symptom burden −19% vs expected — Dosing / Timing Recommendation DT-01
- Day 41 Tolerance state changed — Unstable → Improving
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Inflammatory activity+8
- Toxicity+4
- GI instability-3
- Nutritional resilience-2
What helped?
- Dosing / Timing Recommendation DT-01Day 29Result: symptom burden −19%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable68 min
stable · -2.4 vs previous 14 d
Sleep duration
Wearable7.7 h
stable · -0.2 vs previous 14 d
Energy level
Daily log8.3/10
worsening · -0.4 vs previous 14 d
Steps
Wearable7,866
stable · -173 vs previous 14 d
GI burden
Companion3.2/100
stable · -0.0 vs previous 14 d
Adherence
Companion94.7 %
stable · +0.6 vs previous 14 d
Sleep quality
Wearable60.9/100
stable · -0.4 vs previous 14 d
Glucose, CGM daily mean
CGM119 mg/dL
stable · +3.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 110 from the failing basin, 26 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -4.7 next day on high-intake days · n 19
- More caffeineGI -3 next day on high-intake days · n 16
Would not help
- Keep histamine lowGI +4 next day on high-intake days · n 22
- Keep alcohol lowGI +3.1 next day on high-intake days · n 17
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-4.7supporter · 95%
- Histamine load+4detractor · 95%
- Alcohol+3.1detractor · 90%
- Caffeine-3supporter · 62%
- Insoluble fibre+1.6no signal · 39%
- Simple carbohydrates-1.2no signal · 26%
- Dietary fat load-0.8no signal · 19%
- Ultra-processed food-0.7no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Rapid metabolizerExpected exposure
Microbiome
Shannon diversity 4.4 · butyrate capacity 57/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 55 ms
- Sleep
- 7.8 h
- Steps
- 7,844
- Resting HR
- 66 bpm
Daily log: GI score 3, nutritional resilience 70, adherence 95.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.